DE69916643D1 - Verwendung von hyaluronsäure zur behandlung der bestrahlungs-blasenentzündung - Google Patents

Verwendung von hyaluronsäure zur behandlung der bestrahlungs-blasenentzündung

Info

Publication number
DE69916643D1
DE69916643D1 DE69916643T DE69916643T DE69916643D1 DE 69916643 D1 DE69916643 D1 DE 69916643D1 DE 69916643 T DE69916643 T DE 69916643T DE 69916643 T DE69916643 T DE 69916643T DE 69916643 D1 DE69916643 D1 DE 69916643D1
Authority
DE
Germany
Prior art keywords
hyaluronic acid
inflammation
treating
bubble
treating irradiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69916643T
Other languages
English (en)
Other versions
DE69916643T2 (de
Inventor
J Pommerville
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Teoranta
Original Assignee
Bioniche Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioniche Life Sciences Inc filed Critical Bioniche Life Sciences Inc
Publication of DE69916643D1 publication Critical patent/DE69916643D1/de
Application granted granted Critical
Publication of DE69916643T2 publication Critical patent/DE69916643T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69916643T 1998-10-22 1999-10-22 Verwendung von hyaluronsäure zur behandlung der bestrahlungs-blasenentzündung Expired - Lifetime DE69916643T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10518498P 1998-10-22 1998-10-22
US105184P 1998-10-22
PCT/CA1999/000994 WO2000024387A2 (en) 1998-10-22 1999-10-22 A method for preventing, reducing, and treating radiation cystitis using hyaluronic acid

Publications (2)

Publication Number Publication Date
DE69916643D1 true DE69916643D1 (de) 2004-05-27
DE69916643T2 DE69916643T2 (de) 2005-04-28

Family

ID=22304511

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69916643T Expired - Lifetime DE69916643T2 (de) 1998-10-22 1999-10-22 Verwendung von hyaluronsäure zur behandlung der bestrahlungs-blasenentzündung

Country Status (12)

Country Link
US (2) US6667296B1 (de)
EP (1) EP1124546B1 (de)
JP (1) JP4685242B2 (de)
AT (1) ATE264674T1 (de)
AU (1) AU761158B2 (de)
CA (1) CA2347110C (de)
DE (1) DE69916643T2 (de)
DK (1) DK1124546T3 (de)
ES (1) ES2219070T3 (de)
NZ (1) NZ511068A (de)
PT (1) PT1124546E (de)
WO (1) WO2000024387A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9906619D0 (en) † 1999-03-23 1999-05-19 Zeneca Resins Bv Compositions
WO2005058235A2 (en) * 2003-12-10 2005-06-30 Keryx Biopharmaceuticals, Inc. Methods using sulodexide for the treatment of bladder disease
JP2007233949A (ja) * 2006-03-03 2007-09-13 Kyoto Univ 排尿管理システム
ITMI20061030A1 (it) * 2006-05-26 2007-11-27 Altergon Sa Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica
DE102006060953A1 (de) 2006-12-12 2008-08-07 Farco-Pharma Gmbh Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
HUP0900717A3 (en) * 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
AU2010340067B2 (en) 2009-12-15 2015-03-19 Incept, Llc Implants and biodegradable fiducial markers
RU2557949C1 (ru) * 2014-08-14 2015-07-27 Общество с ограниченной ответственностью "КОЛЕТЕКС" Способ лечения лучевого и интерстициального цистита
WO2016146573A1 (en) * 2015-03-13 2016-09-22 Repoceuticals Aps Melatonin for preventing and treating radiation cystitis
RU2676431C1 (ru) * 2018-02-26 2018-12-28 Федеральное государственное бюджетное учреждение "Российский научный центр радиологии и хирургических технологий имени академика А.М. Гранова" Министерства здравоохранения Российской Федерации (ФГБУ "РНЦРХТ им. ак. А.М. Гранова" Минздрава России) Способ моделирования лучевого цистита
EP3810125A4 (de) * 2018-06-03 2022-02-23 Glycomira Therapeutics, Inc. Verfahren zur verhinderung einer schwerwiegenden gesundheitsauswirkung und/oder gewebeschädigung nach exposition mit ionisierender strahlung und/oder chemotherapie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN181358B (de) * 1995-02-14 1998-05-30 Bioniche Inc
US5880108A (en) 1995-02-14 1999-03-09 Bioniche, Inc. Method for treating the internal urinary bladder and associated structures using hyaluronic acid
CA2154103C (en) 1995-07-18 1998-02-24 Samuel Simon Asculai Treatment of mucous membrane disease, trauma or condition and for the relief of pain
CA2247389C (en) 1996-12-27 2009-11-24 Seikagaku Corporation Agent for treatment of bladder troubles

Also Published As

Publication number Publication date
ES2219070T3 (es) 2004-11-16
ATE264674T1 (de) 2004-05-15
EP1124546B1 (de) 2004-04-21
CA2347110C (en) 2008-08-26
PT1124546E (pt) 2004-08-31
CA2347110A1 (en) 2000-05-04
US20040152662A1 (en) 2004-08-05
US6667296B1 (en) 2003-12-23
JP4685242B2 (ja) 2011-05-18
EP1124546A2 (de) 2001-08-22
AU761158B2 (en) 2003-05-29
WO2000024387A2 (en) 2000-05-04
DE69916643T2 (de) 2005-04-28
JP2002528410A (ja) 2002-09-03
AU6455899A (en) 2000-05-15
NZ511068A (en) 2003-10-31
DK1124546T3 (da) 2004-08-09
WO2000024387A3 (en) 2000-08-03

Similar Documents

Publication Publication Date Title
ATE306251T1 (de) Verwendung eines biologisch abbaubaren polymers
FI935851A0 (fi) Antiallergisk sammansaettning foer oftalmiskt eller nasalt bruk
BR0015110A (pt) Métodos de tratamento de doenças de proliferação celular, de tratamento de um distúrbio associado com a atividade da cinesina ksp, de inibição da cinesina ksp, de triagem de moduladores da cinesina kps e de triagem de compostos que se ligam na cinesina ksp, e, compostos
ATE283673T1 (de) Intravesikaler ballon
DE69916643D1 (de) Verwendung von hyaluronsäure zur behandlung der bestrahlungs-blasenentzündung
ATE404522T1 (de) Lipoxinverbindungen und deren verwendung zur behandlung der zellenwucherungsstörung
SE8503680L (sv) Indolderivat
BR0112361A (pt) Métodos para tratamento de condições oculares mediadas por inflamação
DK1071417T3 (da) Anvendelse af cannabidiol som anti-inflammatorisk middel
NO20050450L (no) Kombinasjon av ZD6474, en inhibitor av vaskulaer endotelial vekst faktor reseptor, med radioterapi ved behandling av kreft
BR0309278A (pt) Composto, composição, métodos para modular a atividade da cinesina ksp, para inibir a ksp, para o tratamento de uma doença proliferativa celular, e, uso de um composto
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
DE69939956D1 (de) Verwendung von Myoblasten zur Herstellung eines Medikaments zur Behandlung der stressbedingten Harninkontinenz
BR9710940A (pt) Processo para aumentar a taxa de solubilidade de um filme solúvel em água
NO953995L (no) Ionenolymere som anthelmintica i dyr
ATE543451T1 (de) Bioabsorbierbare, osteogenetische knochenplatte
DK0434625T3 (da) IGF-I til behandling af bivirkninger ved steroidterapi
ATE217800T1 (de) Bioabbaubare, injizierbare oligomer-polymer- zusammensetzung
BR9915431A (pt) Composição de revestimento por eletrorrevestimento catódico
BR9915712A (pt) Usos de ciclobutilalquilaminas substituìdas com arila, e da sibutramina e seus enanciÈmeros e seus sais farmaceuticamente apropriados, e, método para o tratamento da incontinência urinária
TR200101346T2 (tr) Rilüzol ve alfa-tokoferol bileşimi
BR9608721A (pt) Composição farmacêutica, e, processo para tratar inflamação
DK0711163T3 (da) Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF
DK1463541T3 (da) Biomaterialer baseret på hyaluronsyrebenzylester til anti-angiogen terapi i behandling af tumorer
RU97101420A (ru) Способ лечения тонзиллита

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIONICHE TEORANTA, GALWAY, IR